Neumora Therapeutics Inc header image

Neumora Therapeutics Inc

NMRA

Equity

ISIN null / Valor 129329732

NASDAQ (2026-10-27)
USD 0.37-6.31%

Neumora Therapeutics Inc
UMushroom community rating:

star star star star star
3.38 2 votes No rating yet
NegativeNeutralPositive

About company

Neumora Therapeutics Inc is a biotechnology firm dedicated to revolutionizing the treatment of brain diseases through innovative approaches in neuroscience. The company is at the forefront of developing medications aimed at addressing neuropsychiatric disorders and neurodegenerative diseases, which are known for their complexity and varied manifestations. Neumora's strategy involves targeting therapeutically relevant mechanisms within the central nervous system (CNS) with the goal of discovering treatments that are both novel and superior in their pharmacological effects. Additionally, the company employs a precision medicine framework to dissect the biological underpinnings of brain diseases, enabling the identification of specific patient groups who could benefit most from their therapies. This dual focus on groundbreaking pharmacology and targeted treatment approaches positions Neumora Therapeutics Inc as a key player in the quest to provide more effective solutions for conditions that have long challenged the medical community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-86.3%1Y
-96.8%3Y
%5Y

Performance

127%1Y
141%3Y
141%5Y

Volatility

Market cap

69 M

Market cap (USD)

Daily traded volume (Shares)

1,744,660

Daily traded volume (Shares)

1 day high/low

11.47 / 10.87

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.38

2 votes
Performance:
starstarstarstarstar
2.75
Innovation:
starstarstarstarstar
3.75
Society:
starstarstarstarstar
4.38
Nature:
starstarstarstarstar
1.00
Ultima Thule
UK, 22 Oct 2026
star star star star star
Watch the momentum soon, everything is quite obvious.
Viktor Stockel
Switzerland, 27 Oct 2025
star star star star star
Neumora Therapeutics focuses on precision neuroscience, developing therapies for depression, anxiety, and neurological disorders. Its AI-driven approach is innovative, addressing major unmet needs in mental health. High potential, but still early-stage and volatile.

EQUITIES OF THE SAME SECTOR

LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 83.79
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 17.26
DBV Technologies SA
DBV Technologies SA DBV Technologies SA Valor: 2857349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.24%EUR 1.85
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%CHF 83.35
MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.72%SEK 543.00
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%SEK 40.00
Dynavox Group AB
Dynavox Group AB Dynavox Group AB Valor: 114900704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.90%SEK 72.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 151.95
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.43%USD 72.15
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 35.38